Legend Biotech Corp. (LEGN)
19.10
+0.38
(+2.06%)
USD |
NASDAQ |
Oct 07, 16:00
19.10
0.00 (0.00%)
After-Hours: 20:00
Legend Biotech EPS Diluted (Quarterly) : 0.1716 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.1716 |
| March 31, 2026 | -0.2942 |
| December 31, 2025 | -0.1673 |
| September 30, 2025 | -0.2152 |
| June 30, 2025 | -0.6833 |
| March 31, 2025 | -0.5492 |
| December 31, 2024 | 0.1426 |
| September 30, 2024 | -0.6831 |
| June 30, 2024 | -0.0996 |
| March 31, 2024 | -0.3285 |
| December 31, 2023 | -0.7961 |
| September 30, 2023 | -0.3422 |
| June 30, 2023 | -1.136 |
| March 31, 2023 | -0.6784 |
| Date | Value |
|---|---|
| December 31, 2022 | -0.8232 |
| September 30, 2022 | -0.5216 |
| June 30, 2022 | -1.248 |
| March 31, 2022 | -0.2092 |
| December 31, 2021 | -0.6026 |
| September 30, 2021 | -0.865 |
| June 30, 2021 | -0.6612 |
| March 31, 2021 | -0.6785 |
| December 31, 2020 | -0.4382 |
| September 30, 2020 | -0.5035 |
| June 30, 2020 | -1.251 |
| March 31, 2020 | -0.335 |
| December 31, 2019 | -0.4844 |
| September 30, 2019 | -0.2106 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Gilead Sciences, Inc. | -8.444 |
| Ionis Pharmaceuticals, Inc. | -0.6931 |
| Johnson & Johnson | 2.268 |
| Arbutus Biopharma Corp. | -0.026 |
| Capricor Therapeutics, Inc. | -0.7032 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 33.25M |
| Revenue (Quarterly) | 388.14M |
| Total Expenses (Quarterly) | 354.89M |
| Enterprise Value | 2.941B |
| Gross Profit Margin (Quarterly) | 61.52% |
| Profit Margin (Quarterly) | 8.57% |
| Earnings Yield | -2.64% |
| Normalized Earnings Yield | -2.581 |